NCT04571996View on ClinicalTrials.gov

Blood-Brain Barrier Penetration of Therapeutic Agents in Human

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

October 29, 2020

Primary Completion Date

February 23, 2021

Study Completion Date

February 23, 2021

Conditions
CNS Disease
Interventions
DRUG

ODM-104

Capsule

DRUG

Paracetamol

Rapidly dissolving tablet

Trial Locations (1)

Unknown

CRST Turku, Turku

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT04571996 - Blood-Brain Barrier Penetration of Therapeutic Agents in Human | Biotech Hunter | Biotech Hunter